Ryan T. Sullivan, Senior VP and General Counsel at Anacor Pharmaceuticals, Inc. (ANAC), sold 1,466 shares at $110.44 ($164K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $164k ANAC by Senior VP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.44 | 200 | $22K | 13.5% |
| 2 | $110.44 | 200 | $22K | 13.5% |
| 3 | $112.05 | 333 | $37K | 22.8% |
| 4 | $112.05 | 333 | $37K | 22.8% |
| 5 | $112.69 | 200 | $23K | 13.8% |
| 6 | $112.69 | 200 |
| $23K |
| 13.8% |
| Total | $111.78 avg | 1,466 | $164K | 100% |
| Filing → |
| ANAC | SELL | 2016-04-29 | $415K | — | Filing → |
| ANAC | SELL | 2015-12-11 | $1.1M | — | Filing → |
| ANAC | SELL | 2015-05-01 | $168K | — | Filing → |